191
Views
3
CrossRef citations to date
0
Altmetric
VDR, RANKL and OPG Polymorphism and Postmenopausal Osteoporosis

VDR, RANKL and OPG polymorphisms as possible predisposing cofactors of postmenopausal osteoporosis: explorative study in Italian population

, , , , , , & show all
Pages 937-941 | Received 28 Mar 2017, Accepted 22 Apr 2017, Published online: 10 May 2017

References

  • NIH. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785–95.
  • Pansini F, Cervellati C, Guariento A, et al. Oxidative stress, body fat composition, and endocrine status in pre- and postmenopausal women. Menopause 2008;15:112–8.
  • Takahashi TA, Johnson KM. Menopause. Med Clin North Am 2015;99:521–34.
  • Hofbauer LC, Neubauer A, Heufelder AE. Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases. Cancer 2001;92:460–70.
  • Cervellati C, Romani A, Cremonini E, et al. Higher urinary levels of 8-Hydroxy-2′-deoxyguanosine are associated with a worse RANKL/OPG ratio in postmenopausal women with osteopenia. Oxid Med Cell Longev 2016;2016:6038798.
  • Kostenuik PJ. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 2005; 5:618–25.
  • Christakos S, Hewison M, Gardner DG, et al. Vitamin D: beyond bone. Ann N Y Acad Sci 2013;1287:45–58.
  • Wu S, Liu Y, Zhang L, et al. Genome-wide approaches for identifying genetic risk factors for osteoporosis. Genome Med 2013;5:44.
  • Xiong D-H, Shen H, Zhao L-J, et al. Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. J Bone Miner Res 2006;21:1678–95.
  • Vidal C, Formosa R, Xuereb-Anastasi A. Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. J Mol Endocrinol 2011;47:327–33.
  • Mencej S, Albagha OME, Prezelj J, et al. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis. J Mol Endocrinol 2008;40:273–9.
  • Morrison N. a, Qi JC, Tokita a, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284–7.
  • Riggs LB, Nguyen TV, Melton JL, et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995;10:991–6.
  • Chen H-Y, Chen W-C, Hsu C-D, et al. Relation of vitamin D receptor FokI start codon polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal women in Taiwan. Acta Obstet Gynecol Scand 2002;81:93–8.
  • Horst-Sikorska W, Kalak R, Wawrzyniak A, et al. Association analysis of the polymorphisms of the VDR gene with bone mineral density and the occurrence of fractures. J. Bone Miner. Metab 2007;25:310–9.
  • Oei L, Estrada K, Duncan EL, et al. Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 bmd locus versus lessons learned from challenging phenotype definition. Bone 2013;59:20–7.
  • Estrada K, Styrkarsdottir U, Evangelou E, et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012;44:491–501.
  • Karasik D, Rivadeneira F, Johnson ML. The genetics of bone mass and susceptibility to bone diseases. Nat Rev Rheumatol 2016;12:496.
  • Harlow SD, Crawford S, Dennerstein L, et al. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric 2007;10:112–19.
  • Cervellati C, Pansini FS, Bonaccorsi G, et al. Body mass index is a major determinant of abdominal fat accumulation in pre-, peri- and post-menopausal women. Gynecol Endocrinol 2009;25:413–17.
  • Lum A, Le Marchand L. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol Biomarkers Prev 1998;7:719–24.
  • Soufi M, Schoppet M, Sattler AM, et al. Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab 2004;89:3764–8.
  • Mencej S, Prezelj J, Kocijancic A, et al. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women. Maturitas 2006;55:219–26.
  • Bid HK, Konwar R, Aggarwal CG, et al. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci 2009;63:187–94.
  • Sansoni V, Perego S, Colombini A, et al. Interplay between low plasma RANKL and VDR-FokI polymorphism in lumbar disc herniation independently from age, body mass, and environmental factors: a case-control study in the Italian population. Eur Spine J 2016;25:192–9.
  • Gennari L, Becherini L, Mansani R, et al. FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res 1999;14:1379–86.
  • Conti V, Russomanno G, Corbi G, et al. A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy. Int J Mol Sci 2015;16:5452–66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.